Oragenics Average Inventory from 2010 to 2026

OGEN Stock  USD 0.86  0.03  3.61%   
Oragenics Average Inventory yearly trend continues to be very stable with very little volatility. Average Inventory is likely to grow to about 201.9 K this year. Average Inventory is the average amount of inventory Oragenics holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. View All Fundamentals
 
Average Inventory  
First Reported
2010-12-31
Previous Quarter
184.9 K
Current Value
201.9 K
Quarterly Volatility
20.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Oragenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oragenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 25.5 K or Selling General Administrative of 4.3 M, as well as many indicators such as Price To Sales Ratio of 2.9 K, Dividend Yield of 4.0E-4 or Days Sales Outstanding of 7.16. Oragenics financial statements analysis is a perfect complement when working with Oragenics Valuation or Volatility modules.
  
Build AI portfolio with Oragenics Stock
Check out the analysis of Oragenics Correlation against competitors.
To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.
Evaluating Oragenics's Average Inventory across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Oragenics's fundamental strength.

Latest Oragenics' Average Inventory Growth Pattern

Below is the plot of the Average Inventory of Oragenics over the last few years. It is the average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. Oragenics' Average Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oragenics' overall financial position and show how it may be relating to other accounts over time.
Average Inventory10 Years Trend
Slightly volatile
   Average Inventory   
       Timeline  

Oragenics Average Inventory Regression Statistics

Arithmetic Mean175,304
Geometric Mean174,194
Coefficient Of Variation11.90
Mean Deviation18,828
Median160,754
Standard Deviation20,863
Sample Variance435.2M
Range45.5K
R-Value(0.41)
Mean Square Error387.4M
R-Squared0.17
Significance0.10
Slope(1,681)
Total Sum of Squares7B

Oragenics Average Inventory History

2026201.9 K
2025184.9 K
2014160.8 K

About Oragenics Financial Statements

Oragenics investors utilize fundamental indicators, such as Average Inventory, to predict how Oragenics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Average Inventory184.9 K201.9 K

Pair Trading with Oragenics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oragenics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will appreciate offsetting losses from the drop in the long position's value.

Moving against Oragenics Stock

  0.61EQ EquilliumPairCorr
  0.57CMB Cambium BioPairCorr
  0.31GXEA Galapagos NVPairCorr
The ability to find closely correlated positions to Oragenics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oragenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oragenics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oragenics to buy it.
The correlation of Oragenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oragenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oragenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oragenics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Oragenics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oragenics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oragenics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oragenics Stock:
Check out the analysis of Oragenics Correlation against competitors.
To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Biotechnology sector continue expanding? Could Oragenics diversify its offerings? Factors like these will boost the valuation of Oragenics. Anticipated expansion of Oragenics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oragenics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
48.21
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.71)
Return On Equity
(1.69)
Investors evaluate Oragenics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oragenics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Oragenics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Oragenics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oragenics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Oragenics' market price signifies the transaction level at which participants voluntarily complete trades.